Count | |
1 | |
1 | |
4 | |
11 | |
2 | |
1 | |
1 | |
1 | |
4 | |
3 | |
4 | |
2 | |
4 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Rifabutin/adverse effects/economics/pharmacokinetics/*therapeutic use | 1 |
2 | |
3 | |
3 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
7 | |
1 | |
1 | |
1 | |
1 | |
4 | |
12 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
12 | |
3 | |
1 | |
1 | |
1 | |
1 | |
4 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
3 | |
1 | |
1 | |
1 | |
4 | |
4 | |
2 | |
2 | |
1 | |
1 | |
2 | |
1 | |
2 | |
19 | |
1 | |
2 | |
1 | |
1 | |
2 | |
1 | |
2 | |
2 | |
2 | |